Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Allovir Inc ALVR

Healthcare Biotechnology
AlloVir, Inc. is an allogeneic T cell immunotherapy company with a focus on restoring natural immunity against life-threatening viral diseases in pediatric and adult patients with weakened immune systems. The company’s proprietary technology platforms leverage off-the-shelf, allogeneic, single- and multi-virus-specific T cells for patients with T cell deficiencies who are at risk from the life... see more

Recent & Breaking News (NDAQ:ALVR)

Class Action Filed Against AlloVir, Inc. (ALVR) Seeking Recovery for Investors - Contact Levi & Korsinsky

Accesswire February 13, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AlloVir, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALVR

Accesswire February 13, 2024

Investors Who Lost Money on AlloVir, Inc.(ALVR) Should Contact Levi & Korsinsky About Pending Class Action - ALVR

Accesswire February 13, 2024

DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the Firm

Accesswire February 13, 2024

Investors who lost money on AlloVir, Inc. (ALVR) should contact Levi & Korsinsky about pending Class Action - ALVR

Accesswire February 13, 2024

Class Action Filed Against AlloVir, Inc. (ALVR) - March 19, 2024 Deadline to Join - Contact Levi & Korsinsky

Accesswire February 13, 2024

ALVR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Reminds AlloVir Inc. Investors to Join the Class Action Lawsuit!

Accesswire February 13, 2024

AlloVir Deadline Alert

Newsfile February 12, 2024

INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the Firm

Newsfile February 12, 2024

ALLOVIR INVESTOR ALERT: Kirby McInerney LLP Notifies AlloVir, Inc. (ALVR) Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit

Business Wire February 12, 2024

Shareholders that lost money on AlloVir, Inc.(ALVR) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

Accesswire February 12, 2024

Lost Money on AlloVir, Inc.(ALVR)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky

Accesswire February 12, 2024

ALVR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Reminds AlloVir Inc. Investors to Join the Class Action Lawsuit!

Accesswire February 12, 2024

Shareholders that lost money on AlloVir, Inc.(ALVR) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

Accesswire February 11, 2024

AlloVir Shareholder Action Reminder

Newsfile February 11, 2024

AlloVir, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your Rights - ALVR

Accesswire February 11, 2024

March 19, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against ALVR

Accesswire February 11, 2024

ALVR SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AlloVir Inc. Investors Can Join the Class Action Lawsuit!

Accesswire February 11, 2024

ALVR LAWSUIT ALERT: Levi & Korsinsky Notifies AlloVir, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

Accesswire February 9, 2024

ROSEN, SKILLED INVESTOR COUNSEL, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALVR

PR Newswire February 9, 2024